Mazor Robotics (MZOR) Receives Hold Rating from Needham & Company LLC
“MZOR reported revenue and EPS that were below consensus. On 11/19/18, MZOR will hold a shareholder vote to confirm MDT’s proposed acquisition. We see no reason to believe the deal will not be confirmed and we maintain our Hold rating.”,” Needham & Company LLC’s analyst wrote.
Other analysts have also issued reports about the company. BidaskClub raised Mazor Robotics from a buy rating to a strong-buy rating in a report on Friday, October 12th. Zacks Investment Research lowered Mazor Robotics from a hold rating to a sell rating in a report on Thursday, August 9th. Finally, ValuEngine lowered Mazor Robotics from a buy rating to a hold rating in a report on Tuesday, August 28th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $59.90.
Large investors have recently modified their holdings of the company. Natixis boosted its stake in shares of Mazor Robotics by 7.4% in the second quarter. Natixis now owns 57,273 shares of the medical instruments supplier’s stock worth $3,179,000 after acquiring an additional 3,953 shares during the last quarter. First Allied Advisory Services Inc. boosted its stake in shares of Mazor Robotics by 217.2% in the second quarter. First Allied Advisory Services Inc. now owns 14,562 shares of the medical instruments supplier’s stock worth $806,000 after acquiring an additional 9,971 shares during the last quarter. Marshall Wace LLP acquired a new stake in shares of Mazor Robotics in the second quarter worth approximately $240,000. Alps Advisors Inc. acquired a new stake in shares of Mazor Robotics in the second quarter worth approximately $279,000. Finally, Global X Management Co LLC boosted its stake in shares of Mazor Robotics by 19.7% in the second quarter. Global X Management Co LLC now owns 506,196 shares of the medical instruments supplier’s stock worth $28,099,000 after acquiring an additional 83,387 shares during the last quarter. 21.71% of the stock is currently owned by hedge funds and other institutional investors.
About Mazor Robotics
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.
Further Reading: What are the Benefits of Index Funds?
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.